Cosmos Holdings

Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. It is also involved in the research and development of its business units, and acquisition of pharmaceutical companies. The firm offers over-the-counter drugs, branded and generic medicines, and dietary and vitamin supplements. The company was founded on July 21, 2009 and is headquartered in Chicago, IL.

Earnings data Q2 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

AST SpaceMobile

180 Life Sciences 

Canoo

IMARA

Marathon Digital Holdings

Redfin

Short squeeze penny stocks to watch this week. The post Penny Stocks To Buy This Week?

Penny Stocks To Buy This Week? 7 Short Squeeze Stocks To Watch

Short Squeeze Penny Stocks To Watch At The Start Of 2023. The post Penny Stocks To Buy This Week?

Penny Stocks To Buy This Week? 4 Short Squeeze Stocks To Watch

Re-affirming His Commitment to Growth and Profitability CHICAGO, IL / ACCESSWIRE / December 22, 2022 / Cosmos Health, Inc. ("the Company") (Nasdaq:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today that CEO Greg Siokas has participated with $3 million in the approximately $32.5 million financing of the Company completed yesterday, December 21, 2022, increasing to approximately $6 million his personal investments in the Company throughout 2022. Greg Siokas, Chief Executive Officer of Cosmos Health stated, "I continue to be dedicated to the growth and future profitability of Cosmos Health.

Cosmos Health CEO Participated in the Last Fundraising of the Company

CHICAGO, IL / ACCESSWIRE / December 21, 2022 / Cosmos Health Inc. (the "Company") (NASDAQ:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced the closing of its previously announced registered direct offering of 2,828,320 shares of the Company's common stock and concurrent private placement of warrants to purchase 2,828,320 shares of the Company's common stock at a combined purchase price of $11.50. The warrants have an exercise price of $11.50 per share, are exercisable immediately and expire five years from the issuance date.

Cosmos Health Inc. Announces Successful Closing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market

Cosmos Health Inc.'s stock pulled back Monday after the company announced the pricing of a $32.5 million registered direct offering, wiping away Friday's big gains.

Cosmos Health stock tumbles, weighed down by $32.5 million registered direct offering

Cosmos Health (NASDAQ: COSM ) stock is falling hard on Monday after the healthcare company's shares got a boost on Friday. That increase in price for COSM stock came alongside a couple of pieces of news from the company.

Why Is Cosmos Health (COSM) Stock Down 58% Today?

CHICAGO, IL / ACCESSWIRE / December 19, 2022 / Cosmos Health Inc. (the "Company") (Nasdaq:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that it has entered into securities purchase agreements with institutional investors for the purchase and sale of 2,828,320 shares of the Company's common stock in a registered direct offering and warrants to purchase up to 2,828,320 common shares in a concurrent private placement. The combined purchase price for one share of common stock and one warrant will be $11.50.

Cosmos Health Inc. Announces Pricing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market

Cosmos Health Inc.'s stock price nearly tripled Friday as investors responded to the company's reverse stock split.

Cosmos Health stock rockets on reverse stock split

Cosmos (NASDAQ: COSM ) stock is on the move Friday as the healthcare company undergoes a name change and a reverse stock split today. The name change saw the company moving from the Cosmos Holdings name to its new Cosmos Health name.

COSM Stock Alert: What to Know As Cosmos' Reverse Stock Split Takes Effect

Core Scientific

Troika Media Group

Use these methods to find penny stocks The post Top Methods for Building A Penny Stocks Portfolio  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Top Methods for Building A Penny Stocks Portfolio

Ambrx Biopharma

ComSovereign Holding

Use these tips for evaluating penny stocks to buy The post How to Find and Evaluate Penny Stocks For Your Portfolio  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

How to Find and Evaluate Penny Stocks For Your Portfolio

CHICAGO, IL / ACCESSWIRE / December 9, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (NASDAQ:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced that it has retained Shareholder Intelligence Services, LLC ("ShareIntel"), to review the trading patterns of the Company's common stock for the past two years and going forward. The Company values its shareholders and wants to have all available data at its disposal to act in its fiduciary capacity.

Cosmos Health Retains Shareholder Intelligence Services, LLC

3D Systems

Live Nation

Carvana

Karat Packaging

Prologis

Rocket Companies, Inc.

Insiders can sell for a whole host of reasons, including to make other investments, buy a house and pay for life's expenses.

Insider Buying in 3D Systems, Live Nation and 5 Others

Ambev

Rigel Pharmaceuticals

Use these tips for trading penny stocks right now The post Don't Invest in Penny Stocks Until You've Read This Article appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Don't Invest in Penny Stocks Until You've Read This Article

CHICAGO, IL / ACCESSWIRE / December 2, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (Nasdaq:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, provided a summary regarding recent share activity, including the participation of CEO, Greg Siokas on all capital raises. Management reiterates its belief in the financial strength of Cosmos Health, and its commitment to the growth and profitability of the Company.

Cosmos Health Provides a Summary Regarding Recent Share Activity and Reiterates its Belief and Commitment to the Financial Strength and the Growth and Profitability of the Company

Cosmos Holdings stock is up 618% in November likely due to a short squeeze. This article explains why Cosmos Holdings may still be a good long-term investment

Cosmos Holdings May be a Long-Term Buy with Short-Term Risk

CHICAGO, IL / ACCESSWIRE / November 29, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (NASDAQ:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that it has entered the development phase for CCX0722, an innovative product for obesity and weight management, based on the effectiveness of biocompatible 3D spatial fillers, from natural ingredients. Spatial fillers are hydrophilic biopolymer grids capable of absorbing and retaining large amounts of water or biological fluids.

Cosmos Health Enters the Development Phase for CCX0722, an Innovative Product for Obesity and Weight Management

Shares of Cosmos (NASDAQ: COSM ) are up by more than 700% this month. Investors have attributed this astounding price action in COSM stock to a short squeeze, as the company has not released any news to cause gains this significant.

5 Investors Betting Big on Cosmos (COSM) Stock

Taboola

This is why trading penny stocks in 2022 is fundamentally different The post Why Buying Penny Stocks in 2022 is Unlike Any Other Time appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Why Buying Penny Stocks in 2022 is Unlike Any Other Time

Helbiz

 Nuwellis

Use these tips for buying penny stocks right now The post Buying Penny Stocks as 2022 Ends? 3 Tips and Tricks  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Buying Penny Stocks as 2022 Ends? 3 Tips and Tricks

Cosmos Holdings (NASDAQ: COSM ) stock is ripping higher on Wednesday, currently up more than 20% so far today. At today's high, though, COSM stock was up more than 100%.

Is a Giant Short Squeeze Brewing in Cosmos (COSM) Stock?

Palisade Bio

Check out these tips for trading penny stocks The post Should You Be Buying Penny Stocks? Here's 3 Reasons Why appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Should You Be Buying Penny Stocks? Here's 3 Reasons Why

Wish

How to trade under $1 penny stocks The post Buying Penny Stocks Under $1? What You Need to Know  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Buying Penny Stocks Under $1? What You Need to Know

CHICAGO, IL / ACCESSWIRE / November 21, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (Nasdaq:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that its Sky Premium Life luxury food supplement brand will be sold on Ronda, the official inflight magazine of the airline company Iberia of BRITISH AIRWAYS group. Ronda is available free of charge to the over 10 million passengers who fly Iberian Airlines annually.

Cosmos Health to Sell its Sky Premium Life Luxury Food Supplement Brand on Iberian Airlines' In-flight Magazine, Ronda.

Ardelyx

This is what penny stocks need to succeed in 2022 The post What Do Penny Stocks Need to Succeed in 2022?  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

News for Cosmos Holdings Stock (COSM)